Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The medications remain covered for conditions like diabetes and heart disease but not for obesity itself
Benefits for Men While PT-141 is not officially FDA-approved for men, it is widely used off-label to address erectile dysfunction (ED) and low libido
Common side effects are typically mild and may include slight redness, dryness, or sensitivity during the initial adjustment period
Currently, there is an ongoing randomised double-masked placebo-controlled trial, the SUMMIT trial, studying the efficacy and safety of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and GLP-1 receptors, versus placebo in HFpEF patients with obesity (NCT04847557)
US$ 24.18
US$ 25.83
US$ 22.57
US$ 21.35
US$ 27.24
